BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 15496527)

  • 1. Biopharmaceuticals derived from genetically modified plants.
    Goldstein DA; Thomas JA
    QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic plants as factories for biopharmaceuticals.
    Giddings G; Allison G; Brooks D; Carter A
    Nat Biotechnol; 2000 Nov; 18(11):1151-5. PubMed ID: 11062432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant-based production of biopharmaceuticals.
    Fischer R; Stoger E; Schillberg S; Christou P; Twyman RM
    Curr Opin Plant Biol; 2004 Apr; 7(2):152-8. PubMed ID: 15003215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in plant molecular farming.
    Obembe OO; Popoola JO; Leelavathi S; Reddy SV
    Biotechnol Adv; 2011; 29(2):210-22. PubMed ID: 21115109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plant-based production of recombinant cytokines].
    Góra-Sochacka A; Redkiewicz P; Napiórkowska B; Sirko A
    Postepy Biochem; 2009; 55(1):85-94. PubMed ID: 19514469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plant-derived vaccines and other therapeutics produced in contained systems.
    Franconi R; Demurtas OC; Massa S
    Expert Rev Vaccines; 2010 Aug; 9(8):877-92. PubMed ID: 20673011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant-made pharmaceuticals: leading products and production platforms.
    Paul M; Ma JK
    Biotechnol Appl Biochem; 2011; 58(1):58-67. PubMed ID: 21446960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant-made pharmaceuticals for the prevention and treatment of autoimmune diseases: where are we?
    Avesani L; Bortesi L; Santi L; Falorni A; Pezzotti M
    Expert Rev Vaccines; 2010 Aug; 9(8):957-69. PubMed ID: 20673017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Neanderthal to nanobiotech: from plant potions to pharming with plant factories.
    Sourrouille C; Marshall B; Liénard D; Faye L
    Methods Mol Biol; 2009; 483():1-23. PubMed ID: 19183890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioreactor technology: a novel industrial tool for high-tech production of bioactive molecules and biopharmaceuticals from plant roots.
    Sivakumar G
    Biotechnol J; 2006 Dec; 1(12):1419-27. PubMed ID: 17136730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plants as bioreactors for biopharmaceuticals: regulatory considerations.
    Miele L
    Trends Biotechnol; 1997 Feb; 15(2):45-50. PubMed ID: 9081298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-made therapeutics: an emerging platform in South Africa.
    Rybicki EP; Chikwamba R; Koch M; Rhodes JI; Groenewald JH
    Biotechnol Adv; 2012; 30(2):449-59. PubMed ID: 21839824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in therapeutic glycoprotein production.
    Sethuraman N; Stadheim TA
    Curr Opin Biotechnol; 2006 Aug; 17(4):341-6. PubMed ID: 16828275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody production by molecular farming in plants.
    Fischer R; Hoffmann K; Schillberg S; Emans N
    J Biol Regul Homeost Agents; 2000; 14(2):83-92. PubMed ID: 10841283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic antibody production technologies: molecules, applications, expression and purification.
    Humphreys DP; Glover DJ
    Curr Opin Drug Discov Devel; 2001 Mar; 4(2):172-85. PubMed ID: 11378956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient expression systems for plant-derived biopharmaceuticals.
    Komarova TV; Baschieri S; Donini M; Marusic C; Benvenuto E; Dorokhov YL
    Expert Rev Vaccines; 2010 Aug; 9(8):859-76. PubMed ID: 20673010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities for recombinant antigen and antibody expression in transgenic plants--technology assessment.
    Schillberg S; Twyman RM; Fischer R
    Vaccine; 2005 Mar; 23(15):1764-9. PubMed ID: 15734038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seed-based expression systems for plant molecular farming.
    Boothe J; Nykiforuk C; Shen Y; Zaplachinski S; Szarka S; Kuhlman P; Murray E; Morck D; Moloney MM
    Plant Biotechnol J; 2010 Jun; 8(5):588-606. PubMed ID: 20500681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downstream processing of recombinant proteins from transgenic feedstock.
    Nikolov ZL; Woodard SL
    Curr Opin Biotechnol; 2004 Oct; 15(5):479-86. PubMed ID: 15464381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.